Neither FDA nor its HHS masters seem to know how to develop an effective regulatory scheme
Panel: FDA needs more accelerated approvals
November 1, 2012
4:00 am
A White House scientific panel has recommended that FDA expand its accelerated approval program to a broader range of drugs.
PhRMA’s principles for patient input
November 1, 2012
4:00 am
The Pharmaceutical Research and Manufacturers of America (PhRMA) has adopted “principles” to guide interactions between companies and patient organizations.
Hearing patient activists and pharma and agency execs talk about connecting through social and other online channels brings to mind a room full of awkward wallflowers at a high school dance.
AI Deciphered: Discovering the Potential for Marketers and Communicators